USE OF HEPARINASE TO DECREASE INFLAMMATORY RESPONSES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20010006635A1
SERIAL NO

08722659

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell surfaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOMARIN PHARMACEUTICAL INC105 DIGITAL DRIVE NOVATO CA 94949

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BENNETT, D CLARK MONTREAL, CA 6 106
CAUCHON, ELIZABETH MONTREAL, CA 5 38
DANAGHER, PAMELA MONTREAL, CA 4 105
FINK, DOMINIQUE MONTREAL, CA 5 106
GROUIX, BRIGETTE MONTREAL, CA 5 75
HSIA, ARIANE MONTREAL, CA 3 31
ZIMMERMANN, JOSEPH MONTREAL, CA 7 224

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation